HIGHLIGHTS
- who: Jannis Achenbach et al. from the Department of Neurology, Huntington Center North Rhine-Westphalia, StJosef-Hospital Bochum, Department of Nuclear Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany have published the article: Divergent Effects of the Nonselective Adenosine Receptor Antagonist Caffeine in Pre-Manifest and Motor-Manifest Huntingtonu2019s Disease, in the Journal: (JOURNAL)
- what: The aim of this study was to evaluate clinical effects of caffeine consumption in patients suffering from premanifest and Data of the global observational study were used to analyze the course of regarding symptoms onset . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.